The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bias in reporting of endpoints of efficacy and toxicity in randomized clinical trials (RCTs) for women with breast cancer (BC).
Francisco Emilio Vera Badillo
No relevant relationships to disclose
Roman Shapiro
No relevant relationships to disclose
Alberto Ocana
No relevant relationships to disclose
Eitan Amir
No relevant relationships to disclose
Ian Tannock
No relevant relationships to disclose